Need for discriminating between diagnostic and screening efficacy to estimate a biomarker based on case control and cohort studies
Abstract This study proposes the comprehensive index of biomarker (CIB), based on the consistency of a biomarker in case control (Youden index, J) and cohort studies (Crc), to evaluate biomarker efficacy. CIB was calculated as the mean of J and Crc. Analysis of the effect of sensitivity and specific...
Enregistré dans:
Auteur principal: | Liu Hui |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3a69fbe12ad4413f9715a65a1df8e2bd |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Estimating the efficacy of symptom-based screening for COVID-19
par: Alison Callahan, et autres
Publié: (2020) -
Diagnostic Model for Discrimination Between Tuberculous Meningitis and Bacterial Meningitis
par: Ying Luo, et autres
Publié: (2021) -
Microarray-based selection of a serum biomarker panel that can discriminate between latent and active pulmonary TB
par: Zhihui Li, et autres
Publié: (2021) -
AcalPred: a sequence-based tool for discriminating between acidic and alkaline enzymes.
par: Hao Lin, et autres
Publié: (2013) -
Biomarkers for prediction and diagnostics of preeclampsia
par: O. V. Radkov, et autres
Publié: (2018)